“iRASP Therapeutics” among the top 5 most viewed patents on Knowledge Share platform
The IEO project “iRASP – PLATFORM FOR THE DISCOVERY OF NEW TUMOR-SPECIFIC THERAPEUTIC ANTIBODIES” has been ranked among the most viewed biomedical patents on the Knowledge Share platform for the month of May 2023. The project arises from the research activities conducted by Paul Massa under the coordinated supervision of Pier Giuseppe Pelicci and Saverio Minucci and aims to the identification of novel antibodies for cancer immunotherapy using a unique target-agnostic approach.
Learn more about the iRASP platform here!
IEO as Research Partner of the 2023 Edition of the Seed4Innovation program
IEO has renovated its participation as Research Partner of the third edition of the Seed4Innovation scouting program by Fondazione UNIMI and Università degli Studi di Milano.
Also this year, the IEO-TT team will give its contribution to the scouting and the proposal of research projects from IEO and will participate to the selection and evaluation phases of the program.
Looking forward to this exciting edition of the S4I 2023!
Two IEO projects among the winners of the 2022 edition of the Seed4Innovation program
Two IEO projects, “iRASP” coordinated by Paul Massa under the supervision of Pier Giuseppe Pelicci and Saverio Minucci, and “TELIO,” coordinated by Teresa Manzo and Luigi Nezi were awarded during the final ceremony of "SEED4INNOVATION: where innovation grows", the innovation program organized by Fondazione UNIMI and Università degli Studi di Milano.
From IEO-TT, Dr. Marzia Fumagalli, head of IEO-TT office, and Dr. Ilaria Capozzo, associate at IEO-TT, attended the award ceremony.
Congratulations to the IEO researchers and the IEO-TT team that will continue to work together in the next phase of the program in which, under the guidance of mentors, will define a development plan towards the market.
IEO-TT @ the EU-LIFE Tech Transfer Pitching Event 2022
IEO-TT has continued to work closely with the EU-LIFE Tech Transfer Working Group and also this year has contributed to the organization of the EU-LIFE Tech Transfer Pitching Event 2022 that will be held online on October 11th 2022. The event will give researchers from Institutes of the network the opportunity to present their innovative projects to VCs and professionals with venture creation experience that will provide their insights on the potential of the projects to mature into start-ups.
Dr. Teresa Manzo from IEO will present the pitch for the project “TELIO - Unlocking adoptive cell therapy efficacy by lipid-mediated metabolic reprogramming”
Good luck to our pitcher!
IEO projects selected for the second phase of the 2022 edition of Seed4Innovation program
IEO projects among the 44 projects that have been selected to access the second phase of Seed4Innovation, the scouting program promoted by Fondazione UNIMI and Università degli Studi di Milano created to accelerate the development of highly innovative solutions born from research, favouring their industrial or market application.
For the first time IEO has participated as Research Partner of this second edition of the program and IEO-TT has contributed to the scouting and the proposal of projects from IEO researchers and will continue supporting the projects’ teams in the next phases of the program.
Here are the selected projects from IEO patent portfolio:
iRASP: a unique platform to design novel and efficacious immunotherapies for intractable and rare tumors
TELIO - T cell Engineering by Lipid-mediated metabolic reprogramming for Immune Oncology
PP2A - PP2A Activators for the treatment of cancer
System.NullReferenceException: Object reference not set to an instance of an object. at ASP._Page_Views_Partials_Grid_Editors_DocTypeGridEditor_ButtonDTGE_cshtml.Execute() in E:\WEB\IEO\RESEARCH\live.research.educom.it\Views\Partials\Grid\Editors\DocTypeGridEditor\ButtonDTGE.cshtml:line 9 at System.Web.WebPages.WebPageBase.ExecutePageHierarchy() at System.Web.Mvc.WebViewPage.ExecutePageHierarchy() at System.Web.WebPages.WebPageBase.ExecutePageHierarchy(WebPageContext pageContext, TextWriter writer, WebPageRenderingBase startPage) at Umbraco.Web.Mvc.ProfilingView.Render(ViewContext viewContext, TextWriter writer) in D:\a\1\s\src\Umbraco.Web\Mvc\ProfilingView.cs:line 25 at System.Web.Mvc.Html.PartialExtensions.Partial(HtmlHelper htmlHelper, String partialViewName, Object model, ViewDataDictionary viewData) at Our.Umbraco.DocTypeGridEditor.Web.Extensions.HtmlHelperExtensions.RenderDocTypeGridEditorItem(HtmlHelper helper, IPublishedElement content, String editorAlias, String viewPath, String previewViewPath, Boolean isPreview) at ASP._Page_app_plugins_doctypegrideditor_render_DocTypeGridEditor_cshtml.Execute() in E:\WEB\IEO\RESEARCH\live.research.educom.it\app_plugins\doctypegrideditor\render\DocTypeGridEditor.cshtml:line 28 at System.Web.WebPages.WebPageBase.ExecutePageHierarchy() at System.Web.Mvc.WebViewPage.ExecutePageHierarchy() at System.Web.WebPages.WebPageBase.ExecutePageHierarchy(WebPageContext pageContext, TextWriter writer, WebPageRenderingBase startPage) at Umbraco.Web.Mvc.ProfilingView.Render(ViewContext viewContext, TextWriter writer) in D:\a\1\s\src\Umbraco.Web\Mvc\ProfilingView.cs:line 25 at System.Web.Mvc.Html.PartialExtensions.Partial(HtmlHelper htmlHelper, String partialViewName, Object model, ViewDataDictionary viewData) at ASP._Page_Views_Partials_grid_editors_Base_cshtml.Execute() in E:\WEB\IEO\RESEARCH\live.research.educom.it\Views\Partials\grid\editors\Base.cshtml:line 20
IEO-TT @ the pitching session of the “Evento di brokerage: la ricerca sanitaria incontra l’industria” by APRE
The brokerage event organized by APRE (Agenzia per la Promozione della Ricerca Europea) in collaboration with Farmindustria and Confindustria Medical Devices will take place on 13th-14th of July 2022 at the Ministry of Health in Rome.
The event intends to encourage the development of synergies between research in the health sector and the industrial world representing a great opportunity for institutes carrying out clinical and translational research to interact with companies operating in the pharmaceutical and diagnostics sector.
Dr. Paula Massa will be pitching the project “iRASP Therapeutics” arising from research activities conducted at IEO. Good luck!
Italian Angel for Growth, MSD Italia and MSD Business Development&Licensing visiting IEO
IEO-TT organized a one-day meeting with a delegation of Italian Angels for Growth, the largest group of professional business angels in Italy, MSD Italia, one of the most innovative pharmaceutical companies globally, and MSD Business Development & Licensing unit that visited IEO’s laboratories of the Department of Experimental Oncology.
During the visit Prof. Roberto Orecchia, IEO Scientific Director, Prof. Pier Giuseppe Pelicci, Director of IEO Research, and Prof. Giuseppe Curigliano, Director of Division of Early Drug Development for Innovative Treatment, had the opportunity to showcase the innovative research conducted at IEO aiming at establishing synergies with the company and generating creating more innovation and value for entire health sector.
Dr. Marzia Fumagalli, Head of IEO-TT, Dr. Ilaria Capozzo, Associate at IEO-TT, Prof. Saverio Minucci, Director New Drugs Program of IEO and Chairman of IEO-TT Board, and Prof. Diego Pasini, Group Leader of the laboratory of Epigenetic Mechanisms in Cancer, participated to this promising meeting.
IEO-TT @ the EU-LIFE Tech Transfer Pitching Event
As part of the EU-LIFE Tech Transfer Working Group, the IEO-TT contributed to the organization of an online pitching event aimed at identifying promising translational projects with the potential for maturing into spin-offs. The event will be held on October 13th and will help the selected pitchers to gain insight in the different aspects required to transform their research projects into new ventures.
Prof. Giuseppe Testa and Dr. Paul Massa will pitch live on virtual stage in front of venture capitalists and professionals with venture creation experience, presenting two promising projects originating from research activities conducted in IEO: “Epigenetic modulators to ameliorate core symptoms of autism spectrum disorder” and “A unique engine to discover and develop novel therapeutic antibodies against tumor-associated targets for intractable tumors” respectively.
Good luck to our pitchers!
IEO-TT @ Meet in Italy for Life Sciences 2021 (“Virtual participation”)
From September 29th to October 1st, IEO-TT will be “virtually” present at Meet in Italy for Life Sciences 2021, the leading national matchmaking and update event for all those interested in the themes of Life Sciences. The seventh edition of the event focuses on the impact of biomedical technologies throughout life by analyzing new trends and perspectives. In this context, companies, start-ups, researchers, investors and players in the life science sector will have the opportunity to discuss and explore new collaboration and partnership opportunities for the development of products, services, projects, and distribution and licensing agreements.
During the event, IEO-TT will participate in the Brokerage Event held on October 1st to set up virtual meetings from the matchmaking platform and explore collaborations and partnership opportunities. Have a look at IEO Marketplace page and contact us to schedule a meeting if interested.
IEO-TT @ Proof of Concept (PoC) Projects in Life Sciences Webinar 2021
IEO, through IEO-TT, is among the organizers of a workshop dedicated to Proof of Concept (PoC) Projects in Life Sciences that will take place online on September 23rd and 28th 2021. Experts from the industrial world and tech transfer professionals will discuss the importance of PoC initiatives, the specific criticalities of the life science sector and the role of institutions and research centers in the realization of a PoC project.
Participation is free. Register at the link here and listen to speakers illustrating experiences and sharing best practice.
Dr. Marzia Fumagalli from IEO-TT will present a PoC project financed by the European Commission from the tech transfer point of view and Dr. Paul Massa, the project leader, will pitch the “iRASP Therapeutics” project stemming from that.
IEO-TT @ the Virtual BioVaria Startup Pitch & Partner Event 2021
Prof. Giuseppe Testa and Dr. Paul Massa will pitch live on virtual stage in front of the BioVaria investor jury members for the potential emerging start-ups “Epi-OUTAUT” and “iRASP Therapeutics” respectively, arising from research activities conducted in IEO.
The interactive Startup Pitch & Partner program will be held on April 26-28 and it is the virtual venue for European life-science and biotech entrepreneurs, founders and startups to present their business idea and network with leading VCs, investors and top biotech/pharma companies
Have a look at:
IEO technologies on the matchmaking virtual platform of Meet in Italy for Life Sciences 2021
IEO-TT is among participants in the ongoing session for virtual meetings, WAITING FOR MEET IN ITALY OF LIFE SCIENCES 2021 (MIT4LS2021), to explore collaboration and partnership opportunities through a matchmaking virtual platform. The physical MIT4LS2021 brokerage event will (hopefully) take place at the end of September 2021 in Genova, Italy. Meet in Italy for Life Sciences aims to showcase Italian excellence in the life science sector and provide an opportunity for discussing ideas with international partners.
Have a look at IEO Marketplace page on the virtual platform to see all the partnering opportunities available and schedule a virtual meeting with us if interested.
IEO-TT @ the digital partnering event TechShare Day 2020
From 11th to the 13th of November, IEO-TT will participate at the digital showcase event TechShare Day 2020 organized by Associazione Netval, UIBM and Politecnico di Torino, that will be dedicated to cutting-edge technologies in the Biotechnology and Biomedical Sciences sectors. During the event exponents of Italian research landscape will share their views on topics related to innovation and technology transfer. The goal of the 3-days event will also be to connect innovators with investors and potential commercial partners.
Visit the page of the event to see the program and find out more about technologies developed by IEO scientists seeking partnering opportunities to schedule a one2one meeting with our innovators.
IEO technologies on the Knowledge Share platform
IEO patented technologies are now available on the Knowledge Share platform. Are you interested in collaborating with IEO and bringing technological innovations into the biomedical market? Click here and take a look at all the partnership opportunities!
February 2020 – POSTPONED TO APRIL 2021 DUE TO COVID EMERGENCY
IEO-TT @ the BioVaria Startup Pitch & Partner Event!
Two potential emerging start-ups, “iRASP Therapeutics” and “Epi-OUTAUT”, originating from the research activities carried out by our prominent scientists Prof. Pelicci, Prof. Minucci and Prof. Testa respectively have been selected for the BioVaria Startup Pitch & Partner Event. Come and meet the IEO-TT team at the event!
IEO-TT @ ASTP “Marketing and Business development” Training course
IEO-TT will attend the training course organized by ASTP association and that will focus on marketing and business development roles in the tech transfer process.
Testimonial from our IEO-TT member Claudia: “Very interactive course, high-quality speakers and lots of case studies and working group time. A great opportunity to learn more about the business development manager role in the tech transfer world and how to best establish, develop and promote new commercial relationships and opportunities”
IEO-TT @ the 2019 Netval Summer Conference
The 2019 Netval Summer Conference will deal with the most important issues in knowledge transfer and has been designed for Knowledge Transfer practitioners at international level. If you are working in the sector of the technology transfer, come to the conference and meet Ilaria of the IEO-TT team!
Watch here the sum-up of the event!
In IEO the new technology transfer office is born, IEO-TT (Innovation & Excellence in Oncology – Technology Transfer).
IEO has created a new office dedicated to technology transfer activities: IEO-TT (Innovation & Excellence in Oncology – Technology Transfer) with the mission of fostering the transformation of knowledge generated by IEO research into innovative products for human health.